Ceramide‐based risk score CERT‐1 improves risk prediction for overall mortality and adverse cardiovascular outcomes in patients with and without cardiovascular disease: A prospective cohort study
Diabetes, Obesity and Metabolism · 2025-03 · 27 (3) · 1488-1497
DOI: 10.1111/dom.16156 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Diabetes, Obesity and Metabolism, online erschienen am 26.12.2024. Verfasst von Alessandro Mantovani und 8 weiteren Autor:innen. Beteiligte Einrichtung: Section of Endocrinology, Diabetes and Metabolism, Department of Medicine, University and Azienda Ospedaliera Universitaria Integrata of Verona, Vero…. Hauptthemen laut MEDLINE: Ceramides, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Diabetic Angiopathies. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Aims
Whether the plasma‐based ceramide‐based risk score CERT1 improves risk prediction for cardiovascular disease (CVD) is uncertain. Materials and Methods Baseline and follow‐up data were combined from two cohorts, 334 patients with established/suspected CVD and 196 patients with type 2 diabetes followed for a median of 74 months (interquartile range 54–79 months). For the calculation of CERT1 risk score, we measured four specific plasma ceramides [Cer(d18:1/16:0), Cer(d18:1/18:0) and Cer(d18:1/24:1)] and their ratios to Cer(d18:1/24:0). Based on the CERT1 risk score, patients were split into four risk categories (low, moderate, increased or high risk). The primary outcome was a composite of overall mortality and incident nonfatal CVD outcomes (including myocardial infarction, ischaemic stroke or permanent atrial fibrillation).
Results
One hundred and thirty‐nine patients developed the primary composite outcome (72 nonfatal CVD outcomes and 67 total deaths) during follow‐up. Baseline CERT1 risk categories were significantly associated with the risk of developing the primary composite outcome (adjusted HR for high vs. low‐risk category 2.43, 95% CI 1.39–4.22, p = 0.002, and adjusted HR for increased vs. low‐risk category 2.16, 95% CI 1.28–3.63, p = 0.004). Receiver operator characteristic curve analysis showed that adding CERT1 risk score to traditional CVD risk factors and pre‐existing CVD, improved the discriminatory capability of the regression model for predicting the primary composite outcome (AUROC 0.691 [95% CI 0.674–0.769] vs. 0.722 [95% CI 0.642–0.742], p = 0.0275).
Conclusions
The ceramide‐based risk score CERT1 risk score improves risk prediction for long‐term risk of overall mortality and adverse cardiovascular outcomes in patients with and without CVD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Section of Endocrinology, Diabetes and Metabolism, Department of Medicine, University and Azienda Ospedaliera Universitaria Integrata of Verona, Verona, Italy.
- Clinical Analysis Laboratory and Transfusional Medicine, Clinical Pharmacology, "IRCCS Sacro Cuore - Don Calabria" Hospital, Negrar di Valpolicella, Italy.
- Division of Cardiology, IRCCS Sacro Cuore-Don Calabria Hospital, Negrar di Valpolicella, Italy.
- Southampton National Institute for Health Research Biomedical Research Centre, University Hospital Southampton, Southampton General Hospital, Southampton, UK.
- Nutrition and Metabolism, Faculty of Medicine, University of Southampton, Southampton, UK.
- Department of Medicine, University of Verona, Verona, Italy.
ORCID-Profile: Christopher D Byrne, Giovanni Targher
Zitieren
APA
Mantovani, A., Lunardi, G., Bonapace, S., Molinero, A. E., Morandin, R., Fiorio, V., Molon, G., Byrne, C. D., & Targher, G. (2025). Ceramide‐based risk score CERT‐1 improves risk prediction for overall mortality and adverse cardiovascular outcomes in patients with and without cardiovascular disease: A prospective cohort study. Diabetes, Obesity and Metabolism, 27(3), 1488-1497. https://doi.org/10.1111/dom.16156
Vancouver
Mantovani A, Lunardi G, Bonapace S, Molinero AE, Morandin R, Fiorio V, et al. Ceramide‐based risk score CERT‐1 improves risk prediction for overall mortality and adverse cardiovascular outcomes in patients with and without cardiovascular disease: A prospective cohort study. Diabetes, Obesity and Metabolism. 2025;27(3):1488-1497. doi:10.1111/dom.16156
BibTeX
@article{Mantovani2025,
author = {Mantovani, Alessandro and Lunardi, Gianluigi and Bonapace, Stefano and Molinero, Agustin E and Morandin, Riccardo and Fiorio, Veronica and Molon, Giulio and Byrne, Christopher D and Targher, Giovanni},
title = {Ceramide‐based risk score CERT‐1 improves risk prediction for overall mortality and adverse cardiovascular outcomes in patients with and without cardiovascular disease: A prospective cohort study},
journal = {Diabetes, Obesity and Metabolism},
year = {2025},
volume = {27},
number = {3},
pages = {1488--1497},
doi = {10.1111/dom.16156}
}
EUVIMED